{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:15:45Z","timestamp":1784852145320,"version":"3.55.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018778","name":"Al-Azhar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The CRISPR-Cas systems are supposed to be associated with antibiotic susceptibility.\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    (\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    ) is a major multidrug-resistant (MDR) pathogen that may cause severe infections. This study aimed to detect the antimicrobial resistance (AMR) of\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    isolates in addition to determine the association between the existence of CRISPR-Cas systems and the presence of AMR in Egypt. The antibiotic susceptibility patterns of 100\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    isolates were determined using the Kirby Bauer disc diffusion and broth microdilution methods. The frequency of carbapenem resistance encoding genes (\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>KPC<\/jats:italic>\n                    <\/jats:sub>\n                    ,\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>OXA<\/jats:italic>\n                    <\/jats:sub>\n                    ,\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>IMP<\/jats:italic>\n                      ,\n                    <\/jats:sub>\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>NDM<\/jats:italic>\n                    <\/jats:sub>\n                    , and\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>VIM<\/jats:italic>\n                    <\/jats:sub>\n                    ), ESBLs encoding genes\n                    <jats:italic>(bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>TEM<\/jats:italic>\n                    <\/jats:sub>\n                    ), aminoglycoside resistance encoding genes\n                    <jats:italic>(aac(3)-Ia<\/jats:italic>\n                    ,\n                    <jats:italic>aac(3)-IIa<\/jats:italic>\n                    , colistin resistance encoding genes\n                    <jats:bold>(<\/jats:bold>\n                    <jats:italic>mcr-1<\/jats:italic>\n                    ,\n                    <jats:italic>mcr-2)<\/jats:italic>\n                    and tetracycline resistance encoding genes (\n                    <jats:italic>tetB<\/jats:italic>\n                    ) were determined using polymerase chain reaction (PCR). The presence or absence of CRISPR-Cas systems was determined by detection of Cas genes (Cas1 or Cas3) in conjunction with one of CRISPR arrays 1, 2 or 3. Kirby Bauer disc diffusion revealed that 95% of isolates were MDR. The resistance rates of\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    isolates to amikacin, meropenem, and colistin were 76%, 67%, and 41% respectively by broth microdilution assay. Among selected 41\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    , the frequency of ESBLs;\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>TEM<\/jats:italic>\n                    <\/jats:sub>\n                    was 92.7%, while the frequency of\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>NDM<\/jats:italic>\n                    <\/jats:sub>\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>OXA<\/jats:italic>\n                    <\/jats:sub>\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>VIM<\/jats:italic>\n                    <\/jats:sub>\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>IMP<\/jats:italic>\n                    <\/jats:sub>\n                    and\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>KPC<\/jats:italic>\n                    <\/jats:sub>\n                    was 95.1%, 95.1%, 39%, 19.5% and 14.6% respectively. The frequency of\n                    <jats:italic>mcr-1<\/jats:italic>\n                    and\n                    <jats:italic>mcr-2<\/jats:italic>\n                    was 70.7% and 65.9%. Additionally, the frequency of\n                    <jats:italic>aac(3)-Ia<\/jats:italic>\n                    was 12.2%, and\n                    <jats:italic>aac(3)-IIa<\/jats:italic>\n                    was 87.8%, while the frequency of\n                    <jats:italic>tetB<\/jats:italic>\n                    was 100%. Our isolates exhibited varied profiles for CRISPR-Cas systems, where 65.9% were positive for CRISPR-Cas system. No general significant positive correlation between AMR and the presence ofCRISPR-Cas system was detected; however, a significant difference is present for imipenem, colistin and chloramphenicol phenotypic resistance andfor aac(3)-IIa and mcr-1 genes (\n                    <jats:italic>P<\/jats:italic>\n                    value\u2009&gt;\u20090.1). A significant positive correlation was detected between AMR for imipenem, colistin and chloramphenicol and for aac(3)-IIa and mcr-1 genes and thepresence of CRISPR-Cas system.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-26706-6","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:49:29Z","timestamp":1764082169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of the existence of CRISPR-Cas system and antimicrobial resistance in multi-drug resistant Klebsiella pneumoniae in Egypt"],"prefix":"10.1038","volume":"15","author":[{"given":"Nagwan Galal","family":"El Menofy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Nassef","family":"Payoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"El-Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"26706_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrmicro3569","volume":"13","author":"KS Makarova","year":"2015","unstructured":"Makarova, K. S. et al. An updated evolutionary classification of CRISPR\u2013Cas systems. Nat. Rev. Microbiol. 13, 722\u2013736 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"26706_CR2","doi-asserted-by":"publisher","first-page":"20200464","DOI":"10.1098\/rstb.2020.0464","volume":"377","author":"E Pursey","year":"2022","unstructured":"Pursey, E., Dimitriu, T., Paganelli, F. L., Westra, E. R. & van Houte, S. Crispr-cas is associated with fewer antibiotic resistance genes in bacterial pathogens. Philos. Trans. R Soc. B. 377, 20200464 (2022).","journal-title":"Philos. Trans. R Soc. B"},{"key":"26706_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrmicro2577","volume":"9","author":"KS Makarova","year":"2011","unstructured":"Makarova, K. S. et al. Evolution and classification of the CRISPR\u2013Cas systems. Nat. Rev. Microbiol. 9, 467\u2013477 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"26706_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12033-021-00422-8","volume":"64","author":"N Bharathkumar","year":"2022","unstructured":"Bharathkumar, N. et al. Crispr\/cas-based modifications for therapeutic applications: a review. Mol. Biotechnol. 64, 355\u2013372 (2022).","journal-title":"Mol. Biotechnol."},{"key":"26706_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1128\/JB.01130-13","volume":"196","author":"A Hatoum-Aslan","year":"2014","unstructured":"Hatoum-Aslan, A., Maniv, I., Samai, P. & Marraffini, L. A. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system. J. Bacteriol. 196, 310\u2013317 (2014).","journal-title":"J. Bacteriol."},{"key":"26706_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/MMBR.00039-13","volume":"78","author":"R Louwen","year":"2014","unstructured":"Louwen, R., Staals, R. H., Endtz, H. P., van Baarlen, P. & van der Oost, J. The role of CRISPR-Cas systems in virulence of pathogenic bacteria. Microbiol. Mol. Biol. Rev. 78, 74\u201388 (2014).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"26706_CR7","doi-asserted-by":"publisher","first-page":"e0225131","DOI":"10.1371\/journal.pone.0225131","volume":"14","author":"NA Mackow","year":"2019","unstructured":"Mackow, N. A. et al. Crispr-cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniae. PLoS One. 14, e0225131 (2019).","journal-title":"PLoS One"},{"key":"26706_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/agronomy12040824","volume":"12","author":"Q Tian","year":"2022","unstructured":"Tian, Q. et al. Application of CRISPR\/Cas9 in rapeseed for gene function research and genetic improvement. Agronomy 12, 824 (2022).","journal-title":"Agronomy"},{"key":"26706_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","volume":"9","author":"A Mayorga-Ramos","year":"2023","unstructured":"Mayorga-Ramos, A. et al. Crispr-cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance. ACS Infect. Dis. 9, 1283\u20131302 (2023).","journal-title":"ACS Infect. Dis."},{"key":"26706_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-019-1687-0","volume":"19","author":"B Havenga","year":"2019","unstructured":"Havenga, B. et al. Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains. BMC Microbiol. 19, 1\u201316 (2019).","journal-title":"BMC Microbiol."},{"key":"26706_CR11","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/antibiotics11040520","volume":"11","author":"L Huang","year":"2022","unstructured":"Huang, L. et al. Bacterial multidrug efflux pumps at the frontline of antimicrobial resistance: an overview. Antibiotics 11, 520 (2022).","journal-title":"Antibiotics"},{"key":"26706_CR12","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.24976\/Discov.Med.202436188.177","volume":"36","author":"AM Algammal","year":"2024","unstructured":"Algammal, A. M. & Behzadi, P. Antimicrobial resistance: a global public health concern that needs perspective combating strategies and new talented antibiotics. Discov Med. 36, 1911\u20131913 (2024).","journal-title":"Discov Med."},{"key":"26706_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/antibiotics14040353","volume":"14","author":"T Karampatakis","year":"2025","unstructured":"Karampatakis, T., Tsergouli, K. & Behzadi, P. Carbapenem-resistant Pseudomonas aeruginosa\u2019s resistome: pan-genomic plasticity, the impact of transposable elements and jumping genes. Antibiotics 14, 353 (2025).","journal-title":"Antibiotics"},{"key":"26706_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/antibiotics13030257","volume":"13","author":"T Karampatakis","year":"2024","unstructured":"Karampatakis, T., Tsergouli, K. & Behzadi, P. Pan-genome plasticity and virulence factors: a natural treasure trove for Acinetobacter baumannii. Antibiotics 13, 257 (2024).","journal-title":"Antibiotics"},{"key":"26706_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis, T., Tsergouli, K. & Behzadi, P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics 12, 234 (2023).","journal-title":"Antibiotics"},{"key":"26706_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani, M. S. et al. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front. Microbiol. 10, 539 (2019).","journal-title":"Front. Microbiol."},{"key":"26706_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/cid\/ciy027","volume":"67","author":"CL Gorrie","year":"2018","unstructured":"Gorrie, C. L. et al. Antimicrobial-resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital. Clin. Infect. Dis. 67, 161\u2013170 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"26706_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/ph18030402","volume":"18","author":"ME Elshobary","year":"2025","unstructured":"Elshobary, M. E. et al. Combating antibiotic resistance: mechanisms, multidrug-resistant pathogens, and novel therapeutic approaches: an updated review. Pharmaceuticals 18, 402 (2025).","journal-title":"Pharmaceuticals"},{"key":"26706_CR19","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.51594\/estj.v5i7.1344","volume":"5","author":"AO Olatunji","year":"2024","unstructured":"Olatunji, A. O. et al. Next-generation strategies to combat antimicrobial resistance: integrating genomics, CRISPR, and novel therapeutics for effective treatment. Eng. Sci. Tech. J. 5, 2284\u20132303 (2024).","journal-title":"Eng. Sci. Tech. J."},{"key":"26706_CR20","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.2147\/IDR.S494327","volume":"2024","author":"MM Ahmed","year":"2024","unstructured":"Ahmed, M. M. et al. Crispr-cas systems in the fight against antimicrobial resistance: current status, potentials, and future directions. Infect. Drug Resist. 2024, 5229\u20135245 (2024).","journal-title":"Infect. Drug Resist."},{"key":"26706_CR21","doi-asserted-by":"crossref","unstructured":"Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S. & Patel, R. Syndromic panel-based testing in clinical microbiology. Clin Microbiol. Rev 31, 1\u201328 (2018).","DOI":"10.1128\/CMR.00024-17"},{"key":"26706_CR22","first-page":"1","volume":"54","author":"M Shoaib","year":"2020","unstructured":"Shoaib, M. et al. A mini-review on commonly used biochemical tests for identification of bacteria. Int. J. Res. Pub. 54, 1\u20137 (2020).","journal-title":"Int. J. Res. Pub"},{"key":"26706_CR23","unstructured":"Weinstein, M. P. Performance standards for antimicrobial susceptibility testing. (2018)."},{"key":"26706_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12866-024-03472-5","volume":"24","author":"T Golpasand","year":"2024","unstructured":"Golpasand, T., Keshvari, M. & Behzadi, P. Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli. BMC Microbiol. 24, 344 (2024).","journal-title":"BMC Microbiol."},{"key":"26706_CR25","doi-asserted-by":"publisher","first-page":"5309350","DOI":"10.1155\/2022\/5309350","volume":"2022","author":"R Odari","year":"2022","unstructured":"Odari, R. & Dawadi, P. Prevalence of multidrug-resistant Klebsiella pneumoniae clinical isolates in Nepal. J. Trop. Med. 2022, 5309350 (2022).","journal-title":"J. Trop. Med."},{"key":"26706_CR26","doi-asserted-by":"publisher","first-page":"126159","DOI":"10.1016\/j.ijbiomac.2023.126159","volume":"251","author":"Q Zhuang","year":"2023","unstructured":"Zhuang, Q. et al. Advances in the detection of $\\beta$-lactamase: a review. Int. J. Biol. Macromol. 251, 126159 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"26706_CR27","doi-asserted-by":"publisher","first-page":"e00276","DOI":"10.1128\/jcm.00276-21","volume":"60","author":"CG Giske","year":"2022","unstructured":"Giske, C. G., Turnidge, J., Cant\u00f3n, R. & Kahlmeter, G. Update from the European committee on antimicrobial susceptibility testing (EUCAST). J. Clin. Microbiol. 60, e00276\u2013e00221 (2022).","journal-title":"J. Clin. Microbiol."},{"key":"26706_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.5455\/javar.2022.i613","volume":"9","author":"MH Effendi","year":"2022","unstructured":"Effendi, M. H. et al. Molecular identification of BlaTEM gene of extended-spectrum beta-lactamase-producing Escherichia coli from healthy pigs in Malang district, East java, Indonesia. J. Adv. Vet. Anim. Res. 9, 447 (2022).","journal-title":"J. Adv. Vet. Anim. Res."},{"key":"26706_CR29","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/antibiotics12060980","volume":"12","author":"NA Jwair","year":"2023","unstructured":"Jwair, N. A., Al-Ouqaili, M. T. & Al-Marzooq, F. Inverse association between the existence of CRISPR\/Cas systems with antibiotic resistance, extended spectrum $\\beta$-lactamase and carbapenemase production in multidrug, extensive drug and pandrug-resistant Klebsiella pneumoniae. Antibiotics 12, 980 (2023).","journal-title":"Antibiotics"},{"key":"26706_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.32598\/rmm.9.2.1189.1","volume":"9","author":"S Asif","year":"2021","unstructured":"Asif, S., Khan, M., Arshad, M. W. & Shabbir, M. I. PCR optimization for beginners: a step by step guide. Res. Mol. Med. 9, 81\u2013102 (2021).","journal-title":"Res. Mol. Med."},{"key":"26706_CR31","first-page":"3923","volume":"62","author":"PY Lee","year":"2012","unstructured":"Lee, P. Y., Costumbrado, J., Hsu, C. Y. & Kim, Y. H. Agarose gel electrophoresis for the separation of DNA fragments. J. Vis. Exp. : JoVE. 62, 3923 (2012).","journal-title":"J. Vis. Exp. : JoVE"},{"key":"26706_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-015-1285-7","volume":"8","author":"ML Ostria-Hern\u00e1ndez","year":"2015","unstructured":"Ostria-Hern\u00e1ndez, M. L., S\u00e1nchez-Vallejo, C. J., Ibarra, J. A. & Castro-Escarpulli, G. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR\/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae. BMC Res. Notes. 8, 1\u201310 (2015).","journal-title":"BMC Res. Notes"},{"key":"26706_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.nmni.2015.06.005","volume":"7","author":"L Rouli","year":"2015","unstructured":"Rouli, L., Merhej, V., Fournier, P. E. & Raoult, D. The bacterial pangenome as a new tool for analysing pathogenic bacteria. New. Microbes New. Infect. 7, 72\u201385 (2015).","journal-title":"New. Microbes New. Infect."},{"key":"26706_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mib.2018.04.004","volume":"45","author":"KL Wyres","year":"2018","unstructured":"Wyres, K. L. & Holt, K. E. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr. Opin. Microbiol. 45, 131\u2013139 (2018).","journal-title":"Curr. Opin. Microbiol."},{"key":"26706_CR35","first-page":"DC08","volume":"8","author":"N Manjula","year":"2014","unstructured":"Manjula, N. et al. Antibiotic susceptibility pattern of ES$\\beta$L producing Klebsiella pneumoniae isolated from urine samples of pregnant women in Karnataka. J. Clin. Diagn. Res. : JCDR. 8, DC08 (2014).","journal-title":"J. Clin. Diagn. Res. : JCDR"},{"key":"26706_CR36","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.22207\/JPAM.14.3.36","volume":"14","author":"SM Abdelhamid","year":"2020","unstructured":"Abdelhamid, S. M., Abd-Elaal, H. M., Matareed, M. O. & Baraka, K. Genotyping and virulence analysis of drug resistant clinical Klebsiella pneumoniae isolates in Egypt. J. Pure Appl. Microbiol. 14, 1967\u20131976 (2020).","journal-title":"J. Pure Appl. Microbiol."},{"key":"26706_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/mdr.2018.0380","volume":"25","author":"HO Khalifa","year":"2019","unstructured":"Khalifa, H. O. et al. High prevalence of antimicrobial resistance in gram-negative bacteria isolated from clinical settings in egypt: recalling for judicious use of conventional antimicrobials in developing nations. Microb. Drug Resist. 25, 371\u2013385 (2019).","journal-title":"Microb. Drug Resist."},{"key":"26706_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/antibiotics10030255","volume":"10","author":"SM Abdelaziz","year":"2021","unstructured":"Abdelaziz, S. M., Abdel-Rahman, M. A., El-Sheikh, H. H. & Azab, E. Correlation between the antibiotic resistance genes and susceptibility to antibiotics among the carbapenem-resistant gram-negative pathogens. Antibiotics 10, 255 (2021).","journal-title":"Antibiotics"},{"key":"26706_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/antibiotics10030247","volume":"10","author":"KS Azab","year":"2021","unstructured":"Azab, K. S. et al. Distribution of extended-spectrum $\\beta$-lactamase (ESBL)-encoding genes among multidrug-resistant gram-negative pathogens collected from three different countries. Antibiotics 10, 247 (2021).","journal-title":"Antibiotics"},{"key":"26706_CR40","doi-asserted-by":"publisher","first-page":"100351","DOI":"10.1016\/j.jgeb.2024.100351","volume":"22","author":"FA Afify","year":"2024","unstructured":"Afify, F. A. et al. Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in egypt: a cross sectional study to assess resistance trends during the COVID-19 pandemic. J. Genet. Eng. Biotechnol. 22, 100351 (2024).","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"26706_CR41","doi-asserted-by":"publisher","first-page":"e0215177","DOI":"10.1371\/journal.pone.0215177","volume":"14","author":"F Moges","year":"2019","unstructured":"Moges, F. et al. High prevalence of extended-spectrum beta-lactamase-producing gram-negative pathogens from patients attending Felege Hiwot comprehensive specialized hospital, Bahir dar, Amhara region. PLoS One. 14, e0215177 (2019).","journal-title":"PLoS One"},{"key":"26706_CR42","doi-asserted-by":"crossref","unstructured":"Al-Ouqaili, M. T., Khalaf, E. A. & Al-Kubaisy, S. H. DNA sequence analysis of BlaVEB gene encoding multi-drug resistant and extended-spectrum $\\beta$-lactamases producer isolates of Enterobacteriaceae and Pseudomonas aeruginosa. Open Microbiol. J 14, 40\u201347 (2020).","DOI":"10.2174\/1874285802014010040"},{"key":"26706_CR43","first-page":"151","volume":"31","author":"MA Anwar","year":"2022","unstructured":"Anwar, M. A. Detection of BlaKPC gene among carbapenem resistant Enterobacteriacae isolates from Ain Shams university hospital, Egypt. Egyp J. Med. Microbiol. 31, 151\u2013156 (2022).","journal-title":"Egyp J. Med. Microbiol."},{"key":"26706_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/pathogens12010121","volume":"12","author":"MS Taha","year":"2023","unstructured":"Taha, M. S. et al. Genotypic characterization of carbapenem-resistant Klebsiella pneumoniae isolated from an Egyptian university hospital. Pathogens 12, 121 (2023).","journal-title":"Pathogens"},{"key":"26706_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12866-024-03301-9","volume":"24","author":"R Baral","year":"2024","unstructured":"Baral, R., Tuladhar, R., Manandhar, S., Singh, A. & Sherchan, S. Detection of Bla Kpc gene among carbapenemase producing Klebsiella pneumoniae isolated from different clinical specimens at tertiary care hospital of Nepal. BMC Microbiol. 24, 144 (2024).","journal-title":"BMC Microbiol."},{"key":"26706_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/jac\/dku530","volume":"70","author":"N Eliakim-Raz","year":"2015","unstructured":"Eliakim-Raz, N. et al. Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials. J. Antimicrob. Chemother. 70, 979\u2013996 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"26706_CR47","doi-asserted-by":"publisher","unstructured":"Mikhail, S. et al. Evaluation of the synergy of ceftazidime-avibactam in combination with meropenem, amikacin, aztreonam, colistin, or fosfomycin against well-characterized multidrug-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa. Antimicrob. Agents Chemot1her. 63, (2019). https:\/\/doi.org\/10.1128\/aac.00779-00719","DOI":"10.1128\/aac.00779-00719"},{"key":"26706_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.36488\/cmac.2024.1.67-78","volume":"26","author":"VE Mikhail","year":"2024","unstructured":"Mikhail, V. E. et al. Antimicrobial resistance of clinical isolates of Klebsiella pneumoniae and Escherichia coli in Russian hospitals: results of a multicenter epidemiological study. Clin. Microbiol. Antimicrob. Chemother. 26, 67\u201378 (2024).","journal-title":"Clin. Microbiol. Antimicrob. Chemother."},{"key":"26706_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","volume":"22","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect. Dis. 22, 401\u2013412 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"26706_CR50","doi-asserted-by":"crossref","unstructured":"Magalh\u00e3es, M. L. & Blanchard, J. S. Aminoglycosides: mechanisms of action and resistance (ed. Mayers, D.L.) Antimicrobial Drug Resistance. Infectious Disease. 171\u2013181 (Humana Press, 2009).","DOI":"10.1007\/978-1-59745-180-2_14"},{"key":"26706_CR51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/antibiotics8040158","volume":"8","author":"P Richter","year":"2019","unstructured":"Richter, P. et al. Using colistin as a Trojan horse: inactivation of gram-negative bacteria with chlorophyllin. Antibiotics 8, 158 (2019).","journal-title":"Antibiotics"},{"key":"26706_CR52","first-page":"109","volume":"32","author":"AK Abu-El-Azayem","year":"2023","unstructured":"Abu-El-Azayem, A. K., Dwedar, R. A., Nashaat, N. & Shash, R. Y. Comparative evaluation of colistin susceptibility testing using agar Dilution and broth microdilution in multidrug-resistant and extensively drug-resistant gram-negative isolates. Egyp J. Med. Microbiol. 32, 109\u2013115 (2023).","journal-title":"Egyp J. Med. Microbiol."},{"key":"26706_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-019-0339-4","volume":"18","author":"MM Zafer","year":"2019","unstructured":"Zafer, M. M. et al. Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients. Ann. Clin. Microbiol. Antimicrob. 18, 1\u20138 (2019).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"26706_CR54","first-page":"127","volume":"4","author":"F Mahmoud","year":"2023","unstructured":"Mahmoud, F. et al. Molecular mechanisms of colistin resistance among multi-drug resistant (MDR) Klebsiella pneumoniae and Escherichia coli isolated from ICU patients and their susceptibility towards Eravacycline. Microbes Infect. Dis. 4, 127\u2013137 (2023).","journal-title":"Microbes Infect. Dis."},{"key":"26706_CR55","first-page":"9","volume":"28","author":"MM Emara","year":"2019","unstructured":"Emara, M. M., Abd-Elmonsef, M. M., Elnasr, A., Elfeky, A. & L. M. & A. E.-E. Study of mcr-1 gene-mediated colistin-resistance in gram-negative isolates in Egypt. Egyp J. Med. Microbiol. 28, 9\u201316 (2019).","journal-title":"Egyp J. Med. Microbiol."},{"key":"26706_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-021-00476-1","volume":"20","author":"M Farhadi","year":"2021","unstructured":"Farhadi, M. et al. High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several $\\beta$-lactamase and integron genes collected from several hospitals in the North of Iran. Ann. Clin. Microbiol. Antimicrob. 20, 1\u20139 (2021).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"26706_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Global Health. 109, 309\u2013318 (2015).","journal-title":"Pathog Global Health"},{"key":"26706_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fmicb.2020.00215","volume":"11","author":"AA Elkhawaga","year":"2020","unstructured":"Elkhawaga, A. A., Hetta, H. F., Osman, N. S., Hosni, A. & El-Mokhtar, M. A. Emergence of Cronobacter Sakazakii in cases of neonatal sepsis in upper egypt: first report in North Africa. Front. Microbiol. 11, 215 (2020).","journal-title":"Front. Microbiol."},{"key":"26706_CR59","doi-asserted-by":"publisher","first-page":"e5053","DOI":"10.7717\/peerj.5053","volume":"6","author":"OR Akinbami","year":"2018","unstructured":"Akinbami, O. R., Olofinsae, S. & Ayeni, F. A. Prevalence of extended spectrum beta lactamase and plasmid mediated quinolone resistant genes in strains of Klebsiella pneumonia, Morganella morganii, leclercia adecarboxylata and Citrobacter freundii isolated from poultry in South Western n2igeria. PeerJ 6, e5053 (2018).","journal-title":"PeerJ"},{"key":"26706_CR60","doi-asserted-by":"publisher","first-page":"100727","DOI":"10.1016\/j.nmni.2020.100727","volume":"37","author":"A Olowo-okere","year":"2020","unstructured":"Olowo-okere, A. et al. Phenotypic and genotypic characterization of clinical carbapenem-resistant Enterobacteriaceae isolates from sokoto, Northwest Nigeria. New. Microbes New. Infect. 37, 100727 (2020).","journal-title":"New. Microbes New. Infect."},{"key":"26706_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","volume":"22","author":"S Shaikh","year":"2015","unstructured":"Shaikh, S. et al. Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment. Saudi J. Biol. Sci. 22, 90\u2013101 (2015).","journal-title":"Saudi J. Biol. Sci."},{"key":"26706_CR62","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4314\/ahs.v21i2.2","volume":"21","author":"RA El-Domany","year":"2021","unstructured":"El-Domany, R. A., El-Banna, T., Sonbol, F. & Abu-Sayedahmed, S. H. Co-existence of NDM-1 and OXA-48 genes in carbapenem resistant Klebsiella pneumoniae clinical isolates in kafrelsheikh, Egypt. Afr. Health Sci. 21, 489\u2013496 (2021).","journal-title":"Afr. Health Sci."},{"key":"26706_CR63","first-page":"1","volume":"31","author":"A ElBaradei","year":"2022","unstructured":"ElBaradei, A. Co-occurrence of blaNDM-1 and blaOXA-48 among carbapenem resistant Enterobacteriaceae isolates causing bloodstream infections in alexandria, Egypt. Egyp J. Med. Microbiol. 31, 1\u20137 (2022).","journal-title":"Egyp J. Med. Microbiol."},{"key":"26706_CR64","first-page":"61","volume":"27","author":"T Mohamed","year":"2018","unstructured":"Mohamed, T., Yousef, L. M., Darweesh, E. I. & Khalil, A. H. Detection and characterization of carbapenem resistant Enterobacteriacea in Sohag university hospitals. Egyp J. Med. Microbiol. 27, 61\u201369 (2018).","journal-title":"Egyp J. Med. Microbiol."},{"key":"26706_CR65","doi-asserted-by":"crossref","unstructured":"Urmi, U. L. et al. Genotypic to phenotypic resistance discrepancies identified involving \u03b2-beta\u03b2-lactamase genes, Bla KPC, Bla IMP, Bla NDM-1, and Bla VIM in uropathogenic Klebsiella pneumoniae. Infect. Drug. Resist.,13 2863\u20132875 (2020).","DOI":"10.2147\/IDR.S262493"},{"key":"26706_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1128\/CMR.00015-06","volume":"20","author":"F Depardieu","year":"2007","unstructured":"Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E. & Courvalin, P. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20, 79\u2013114 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"26706_CR67","first-page":"e000233","volume":"4","author":"A Johnning","year":"2018","unstructured":"Johnning, A. et al. The resistomes of six carbapenem-resistant pathogens\u2013a critical genotype\u2013phenotype analysis. Microb. Genom. 4, e000233 (2018).","journal-title":"Microb. Genom"},{"key":"26706_CR68","doi-asserted-by":"publisher","first-page":"ftz040","DOI":"10.1093\/femspd\/ftz040","volume":"77","author":"B Kulengowski","year":"2019","unstructured":"Kulengowski, B. & Burgess, D. S. Imipenem\/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical center. Pathog Dis. 77, ftz040 (2019).","journal-title":"Pathog Dis."},{"key":"26706_CR69","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jiac.2024.03.015","volume":"30","author":"TA Almangour","year":"2024","unstructured":"Almangour, T. A. et al. Novel \u03b2-lactam-\u03b2-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: a multicenter cohort study. J. Infect. Chemother. 30, 1008\u20131014 (2024).","journal-title":"J. Infect. Chemother."},{"key":"26706_CR70","first-page":"35","volume":"5","author":"M Harir Foroush","year":"2018","unstructured":"Harir Foroush, M., Shokoohizadeh, L. & Mirzaee, M. Prevalence of genes encoding aminoglycoside modifying enzymes in clinical isolates of Klebsiella pneumoniae in the hospitals of Borujerd. Int. J. Med. Lab. 5, 35\u201341 (2018).","journal-title":"Int. J. Med. Lab."},{"key":"26706_CR71","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12879-024-09451-5","volume":"24","author":"H Kadkhoda","year":"2024","unstructured":"Kadkhoda, H. et al. Prevalence of the CRISPR-cas system and its association with antibiotic resistance in clinical Klebsiella pneumoniae isolates. BMC Infect. Dis. 24, 554 (2024).","journal-title":"BMC Infect. Dis."},{"key":"26706_CR72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3934\/microbiol.2023011","volume":"9","author":"R Abozahra","year":"2023","unstructured":"Abozahra, R., Gaballah, A. & Abdelhamid, S. M. Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt. AIMS Microbiol. 9, 177 (2023).","journal-title":"AIMS Microbiol."},{"key":"26706_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31083\/j.jmcm.2018.01.001","volume":"1","author":"M Zaki","year":"2018","unstructured":"Zaki, M., ElKheir, N. & Mofreh, M. Molecular study of colistin resistant clinical isolates of Enterobacteriaceae species. J. Clin. Mol. Med. 1, 1\u20134 (2018).","journal-title":"J. Clin. Mol. Med."},{"key":"26706_CR74","first-page":"61","volume":"29","author":"RA Rabie","year":"2020","unstructured":"Rabie, R. A. & Abdallah, A. L. Plasmid mediated colistin resistant genes mcr-1 and mcr-2 among Escherichia coli and Klebsiella pneumoniae isolates at zagazig university hospitals, egypt. Egyp. J. Med. Microbiol. 29, 61\u201366 (2020).","journal-title":"Egyp. J. Med. Microbiol."},{"key":"26706_CR75","first-page":"15","volume":"17","author":"DN Abdelmalak","year":"2025","unstructured":"Abdelmalak, D. N., Hassan, M. G., Nasr, A. & Shaaban, M. T. A comprehensive analysis of antibiotic resistance pattern in nosocomial infections in Egypt. Egyp Acad. J. Biol. Sci. G Microbiol. 17, 15\u201325 (2025).","journal-title":"Egyp Acad. J. Biol. Sci. G Microbiol."},{"key":"26706_CR76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5897\/AJMR2015.7871","volume":"10","author":"AM EL-Ganiny","year":"2016","unstructured":"EL-Ganiny, A. M. et al. Phenotypic and genotypic detection of-lactams resistance in Klebsiella species from Egyptian hospitals revealed carbapenem resistance by OXA and NDM genes. Afr. J. Microbiol. Res. 10, 339\u2013347 (2016).","journal-title":"Afr. J. Microbiol. Res."},{"key":"26706_CR77","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.envpol.2010.03.004","volume":"158","author":"R Tao","year":"2010","unstructured":"Tao, R. et al. Detection of antibiotic resistance and Tetracycline resistance genes in Enterobacteriaceae isolated from the Pearl rivers in South China. Environ. Pollut. 158, 2101\u20132109 (2010).","journal-title":"Environ. Pollut"},{"key":"26706_CR78","first-page":"205","volume":"22","author":"E Sheykhsaran","year":"2018","unstructured":"Sheykhsaran, E. et al. The rate of resistance to tetracyclines and distribution of tetA, tetB, tetC, tetD, tetE, tetG, TetJ and TetY genes in Enterobacteriaceae isolated from azerbaijan, Iran during 2017. Physiol. Pharmacol. 22, 205\u2013212 (2018).","journal-title":"Physiol. Pharmacol."},{"key":"26706_CR79","doi-asserted-by":"crossref","unstructured":"Kashefieh, M., Hosainzadegan, H., Baghbanijavid, S. & Ghotaslou, R. The molecular epidemiology of resistance to antibiotics among Klebsiella pneumoniae isolates in azerbaijan, iran. J Trop. Med. , 12 9195184 (2021).","DOI":"10.1155\/2021\/9195184"},{"key":"26706_CR80","doi-asserted-by":"publisher","first-page":"13523","DOI":"10.1021\/acs.jafc.4c02677","volume":"72","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Microbial degradation of Tetracycline antibiotics: mechanisms and environmental implications. J. Agric. Food Chem. 72, 13523\u201313536 (2024).","journal-title":"J. Agric. Food Chem."},{"key":"26706_CR81","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","volume":"42","author":"HY Kim","year":"2017","unstructured":"Kim, H. Y. Statistical notes for clinical researchers: chi-squared test and fisher\u2019s exact test. Restor. Dent. Endod. 42, 152 (2017).","journal-title":"Restor. Dent. Endod"},{"key":"26706_CR82","doi-asserted-by":"crossref","unstructured":"Tawfick, M. M., Elshamy, A. A. & Mohamed, K. T. & El Menofy, N. G. Gut commensal Escherichia coli, a high-risk reservoir of transferable plasmid-mediated antimicrobial resistance traits. Infect Drug Resist. 15, 1077\u20131091 (2022).","DOI":"10.2147\/IDR.S354884"},{"key":"26706_CR83","doi-asserted-by":"crossref","unstructured":"Elmanakhly, A. R. et al. Carbapenem-resistant Klebsiella pneumoniae: diversity, virulence, and antimicrobial resistance. Infect Drug Resist.  15, 6177\u20136187 (2022).","DOI":"10.2147\/IDR.S387742"},{"key":"26706_CR84","doi-asserted-by":"crossref","unstructured":"Salam, M. A. et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare, 1946 (2023).","DOI":"10.20944\/preprints202305.0555.v1"},{"key":"26706_CR85","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.disamonth.2020.100971","volume":"66","author":"MA Abushaheen","year":"2020","unstructured":"Abushaheen, M. A. et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis. -a-Mon. 66, 100971 (2020).","journal-title":"Dis. -a-Mon"},{"key":"26706_CR86","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/ismej.2015.20","volume":"9","author":"U Gophna","year":"2015","unstructured":"Gophna, U. et al. No evidence of Inhibition of horizontal gene transfer by CRISPR\u2013Cas on evolutionary timescales. ISME J. 9, 2021\u20132027 (2015).","journal-title":"ISME J."},{"key":"26706_CR87","doi-asserted-by":"crossref","unstructured":"Tao, S., Chen, H., Li, N. & Liang, W. The application of the CRISPR-Cas system in antibiotic resistance. Infect Drug Resist. 15, 4155\u20134168 (2022).","DOI":"10.2147\/IDR.S370869"},{"key":"26706_CR88","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/microorganisms11081948","volume":"11","author":"AK Alkompoz","year":"2023","unstructured":"Alkompoz, A. K. et al. Correlation of CRISPR\/Cas and antimicrobial resistance in Klebsiella pneumoniae clinical isolates recovered from patients in Egypt compared to global strains. Microorganisms 11, 1948 (2023).","journal-title":"Microorganisms"},{"key":"26706_CR89","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1093\/nar\/gkab859","volume":"50","author":"R Pinilla-Redondo","year":"2022","unstructured":"Pinilla-Redondo, R. et al. Crispr-cas systems are widespread accessory elements across bacterial and archaeal plasmids. Nucleic Acids Res. 50, 4315\u20134328 (2022).","journal-title":"Nucleic Acids Res."},{"key":"26706_CR90","doi-asserted-by":"crossref","unstructured":"Makarova, K. S. & Koonin, E. V. Annotation and classification of CRISPR-Cas systems. CRISPR: Methods And Protocols 47\u201375 (2015).","DOI":"10.1007\/978-1-4939-2687-9_4"},{"key":"26706_CR91","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41467-019-08736-7","volume":"10","author":"A Papikian","year":"2019","unstructured":"Papikian, A., Liu, W., Gallego-Bartolom\u00e9, J. & Jacobsen, S. E. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 suntag systems. Nat. Commun. 10, 729 (2019).","journal-title":"Nat. Commun."},{"key":"26706_CR92","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/agriculture11121286","volume":"11","author":"JK Hong","year":"2021","unstructured":"Hong, J. K. et al. Multiplex CRISPR\/Cas9 mutagenesis of BrVRN1 delays flowering time in Chinese cabbage (Brassica Rapa L. ssp. pekinensis). Agriculture 11, 1286 (2021).","journal-title":"Agriculture"},{"key":"26706_CR93","doi-asserted-by":"crossref","unstructured":"Bilger, R. et al. Control of a type III-Dv CRISPR\u2013Cas system by the transcription factor RpaB and interaction of its leader transcript with the DEAD-box RNA helicase CrhR. bioRxiv\u00a02023, 2023.2012. 2007.570523. (2023).","DOI":"10.1101\/2023.12.07.570523"},{"key":"26706_CR94","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Quorum sensing inhibits type III-A CRISPR-Cas system activity through repressing positive regulators SarA and ArcR in Staphylococcus aureus. Biorxiv 2023, 2023.2001. 2017.524377 (2023).","DOI":"10.1101\/2023.01.17.524377"},{"key":"26706_CR95","doi-asserted-by":"crossref","unstructured":"Wang, G., Song, G. & Xu, Y. Association of CRISPR\/Cas system with the drug resistance in Klebsiella pneumoniae. Infect Drug Resist.  13, 1929\u20131935 (2020).","DOI":"10.2147\/IDR.S253380"},{"key":"26706_CR96","doi-asserted-by":"publisher","first-page":"e0265884","DOI":"10.1371\/journal.pone.0265884","volume":"17","author":"S Enany","year":"2022","unstructured":"Enany, S. et al. Whole genome sequencing of Klebsiella pneumoniae clinical isolates sequence type 627 isolated from Egyptian patients. PLoS One. 17, e0265884 (2022).","journal-title":"PLoS One"},{"key":"26706_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-021-00455-6","volume":"20","author":"P Gholizadeh","year":"2021","unstructured":"Gholizadeh, P. et al. Role of CRISPR-Cas system on antibiotic resistance patterns of Enterococcus faecalis. Ann. Clin. Microbiol. Antimicrob. 20, 1\u201312 (2021).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"26706_CR98","doi-asserted-by":"crossref","unstructured":"Alduhaidhawi, A. H. M. et al. Prevalence of CRISPR-cas systems and their possible association with antibiotic resistance in Enterococcus faecalis and Enterococcus faecium collected from hospital wastewater. Infect Drug Resist.  15, 1143\u20131154 (2022).","DOI":"10.2147\/IDR.S358248"},{"key":"26706_CR99","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1007\/s00253-022-12144-1","volume":"106","author":"M Soliman","year":"2022","unstructured":"Soliman, M., Said, H. S., El-Mowafy, M., Barwa, R. & Novel PCR detection of CRISPR\/Cas systems in Pseudomonas aeruginosa and its correlation with antibiotic resistance. Appl. Microbiol. Biotechnol. 106, 7223\u20137234 (2022).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"26706_CR100","doi-asserted-by":"crossref","unstructured":"AL-Yozbakee, Z. M. & Mohammad, K. O. Crispr-cas system in multi drugs resistant Klebsiella pneumoniae from different clinical samples and its correlation with antibiotic-resistant genes in Mosul city\/iraq. J Appl. Nat. Sci 16, 820\u2013829 (2024).","DOI":"10.31018\/jans.v16i2.5529"},{"key":"26706_CR101","doi-asserted-by":"publisher","first-page":"e5922","DOI":"10.1097\/MD.0000000000005922","volume":"96","author":"L Ren","year":"2017","unstructured":"Ren, L. et al. Relationship between drug resistance and the clustered, regularly interspaced, short, palindromic repeat-associated protein genes cas1 and cas2 in Shigella from giant panda Dung. Medicine 96, e5922 (2017).","journal-title":"Medicine"},{"key":"26706_CR102","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/jobm.201600589","volume":"57","author":"J Shen","year":"2017","unstructured":"Shen, J., Lv, L., Wang, X., Xiu, Z. & Chen, G. Comparative analysis of CRISPR-Cas systems in Klebsiella genomes. J. Basic. Microbiol. 57, 325\u2013336 (2017).","journal-title":"J. Basic. Microbiol."},{"key":"26706_CR103","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mib.2017.06.003","volume":"37","author":"EJ Sontheimer","year":"2017","unstructured":"Sontheimer, E. J. & Davidson, A. R. Inhibition of CRISPR-Cas systems by mobile genetic elements. Curr. Opin. Microbiol. 37, 120\u2013127 (2017).","journal-title":"Curr. Opin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26706-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:04:22Z","timestamp":1764086662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26706-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26706"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26706-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study obtained its approval from the ethical committees of Faculty of Pharmcy (Girls), Al-Azhar University (Approval number: Rec \u2013 CLAR8B).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"41814"}}